Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672)
Clinical trial NCT00243230 · COMPLETED
Trial details
- NCT number
- NCT00243230
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-19
- Primary completion
- 2007-10-19
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.